These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Dec. 4 through Dec. 10, 2025. Source: VerityData

Original Filings

National Presto Industries (NPK) Albion River Management disclosed a new position in the diversified housewares and defense manufacturer of 362,350 shares. Albion River Management purchased 302,313 of those shares from Oct. 27 through Nov. 28 at per share prices ranging from $93.51 to $109.60.

Following the latest purchases, Albion River Management owns a 5.1% stake in National Presto Industries' outstanding stock. Shares have gained roughly 6.7% in value since the beginning of this year.

Increases in Holdings

Universal Technical Institute $(UTI)$ Coliseum Capital Management raised its stake in the educational institution to 3,971,440 shares. Coliseum Capital did so through the purchase of 1,255,173 shares from Dec. 1 through Dec. 5 at per share prices ranging from $23.01 to $25.50.

Following the latest purchases, Coliseum Capital Management owns 7.3% of Universal Technical Institute's outstanding stock. Shares of Universal Technical Institute have lost just 2.8% of their value since the beginning of this year.

Decreases in Holdings

Impinj $(PI)$ Sylebra Capital lowered its stake in the wireless chip maker to 1,504,377 shares. Sylebra Capital did so through the sale of 324,883 Impinj shares from Nov. 3 through Dec. 3 at per share prices ranging from $155.10 to $202.01.

Following the latest sales, Sylebra Capital continues to own 5% of Impinj's outstanding stock. Shares of Impinj have gained roughly 5.7% in value since the beginning of this year.

Garrett Motion (GTX) Cyrus Capital Partners reduced its stake in the vehicle-parts maker to 11,744,714 shares. Cyrus Capital Partners did so through the sale of 2,360,187 Garrett Motion shares from Nov. 6 through Dec. 5 at per share prices ranging from $15.62 to $17.80.

Following the latest sales, Cyrus Capital Partners continues to own 6% of Garrett Motion's outstanding stock. Shares of Garrett Motion have gained approximately 87.5% in value since the beginning of this year.

NewAmsterdam Pharma$(NAMS)$ Bain Capital Life Sciences lowered its stake in the late-stage biopharmaceutical company to 5,673,913 shares. BCLS did so through the sale of 4,800,000 NewAmsterdam Pharma shares in a privately negotiated block transaction on Dec. 2 at a price of $35.10 per share.

Following the latest sale, BCLS owns about 5% of NewAmsterdam Pharma's outstanding stock, representing overall economic exposure of 6.4% when including prefunded warrants. Shares of NewAmsterdam Pharma have gained roughly 37.2% in value since the beginning of this year.

Email: editors@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

December 12, 2025 18:50 ET (23:50 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.